Effects of Nigella sativa on disease activity, T lymphocytes and inflammatory cytokine profiles in pediatric systemic lupus erythematosus: A randomized controlled trial.
- 2024-11-11
- RCT · n = 32
- Narra J 4(3)
- Wisnu Barlianto
- Desy Wulandari
- Tita L Sari
- Rafika R Rachmaningrum
- Rayi I Asasain
- PubMed: 39816053
- DOI: 10.52225/narra.v4i3.1063
- High evidence
- Clinical
A significant decrease in the SLEDAI-2K score was observed at post-treatment in both the NSO and placebo groups (p<0.001 and p=0.025, respectively). However, disease activity was not significantly different between NSO and placebo groups.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 1 g/day